Core Viewpoint - The event "1 in 20,000 Encounter - Public Welfare Science Popularization Art Exhibition on Rare Disease TGCT" aims to raise awareness about tenosynovial giant cell tumor (TGCT), a rare disease affecting joints, through art and public engagement [1][2][3] Group 1: Disease Awareness and Impact - TGCT has an incidence rate of 1 in 20,000 and is included in the national rare disease directory, with approximately 60,000 new patients diagnosed annually in China [1][3] - Patients often face misdiagnosis and delayed diagnosis, taking an average of 1 to 2 years from first visit to confirmation of the disease [2] - The exhibition features over 100 artworks that express the real-life experiences of TGCT patients, highlighting their daily struggles with symptoms like joint swelling and pain [1][2] Group 2: Collaborative Efforts in Rare Disease Management - The event is organized by multiple stakeholders, including the China Rare Disease Alliance and the Beijing Rare Disease Diagnosis and Treatment and Guarantee Society, emphasizing the need for collaboration in rare disease management [1][4] - Experts call for increased public awareness and education on rare diseases, urging healthcare professionals to engage in outreach and communication with patients [2] - The Chinese government is focusing on building a support system for rare diseases, integrating drug supply and patient management into healthcare policies [3] Group 3: Future Directions and Goals - The ultimate goal of rare disease prevention and treatment is to ensure that every "1 in 20,000" patient does not feel isolated [3] - The exhibition serves as a platform to bridge gaps in understanding and to foster dialogue about rare diseases, aiming to improve both treatment pathways and societal empathy [3][4]

Group 1 - The 2025 International Rare Disease Conference (IRDCC) was recently held in Hainan, focusing on enhancing the diagnosis and treatment capabilities for rare diseases in China [1] - The National Health Commission has established a national rare disease quality control center along with over 20 provincial and 50 municipal quality control centers to ensure standardized treatment across hospitals [1] - A global resolution on rare diseases was initiated by 21 countries, including China, at the World Health Assembly, highlighting the challenges faced by approximately 300 million people worldwide with rare diseases [1] Group 2 - The conference gathered over 1,000 experts and researchers from various fields related to rare diseases, including basic research, clinical diagnosis, policy support, and patient services [2] - The event featured a main forum, 17 sub-forums, closed academic discussions, an innovation exhibition, and public consultation activities [2] - The conference was co-hosted by the China Rare Disease Alliance and the National Rare Disease Diagnosis and Treatment Collaboration Network Office, with support from over 40 international and domestic organizations [2]